Gradual dosing of Lilly drug for Alzheimer’s disease reduces risk of brain swelling 

Starting a more gradual dosing schedule for Eli Lilly's Alzheimer's disease drug Kisunla reduces the percentage of patients suffering from potentially serious brain swelling, according to interim results from a…

WeiterlesenGradual dosing of Lilly drug for Alzheimer’s disease reduces risk of brain swelling 

GSK warns of declining vaccine sales in 2024 due to lower demand for respiratory syncytial virus vaccines

GSK on Wednesday said sales of its vaccines would fall this year after weaker-than-expected sales results for respiratory syncytial virus (RSV) and shingles vaccines in the third quarter, sending its…

WeiterlesenGSK warns of declining vaccine sales in 2024 due to lower demand for respiratory syncytial virus vaccines

WHO says tuberculosis has once again become the leading cause of death from infectious diseases

Tuberculosis has replaced COVID-19 to become the leading cause of death from infectious diseases in 2023, according to a World Health Organisation report released Tuesday that highlights challenges in global…

WeiterlesenWHO says tuberculosis has once again become the leading cause of death from infectious diseases

Google’s success in the cloud, driven by artificial intelligence, bodes well for Amazon and Microsoft

Alphabet, Google's parent company Google's breakthrough sales of cloud services in the July-September quarter bode well for leading cloud providers Microsoft and Amazon.com and signal that the market for computing…

WeiterlesenGoogle’s success in the cloud, driven by artificial intelligence, bodes well for Amazon and Microsoft